Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal protein binding	SPTBN5 DLG5 KCNC1 MYO7A CETN3 STRBP SPTBN2 LMTK2 TLN2 FHDC1 MAST2 UTRN MYBPC2	6.25e-05	1099	67	13	GO:0008092
GeneOntologyMolecularFunction	cell adhesion molecule binding	EPS15 EPS15L1 SPTBN2 CAST TLN2 BZW1 UTRN GFRA1 SLC3A2	1.68e-04	599	67	9	GO:0050839
GeneOntologyMolecularFunction	structural molecule activity	COL6A1 LMNB1 VWA5A SPTBN2 H1-3 H1-5 NUP133 TLN2 SPOCK2 H1-1 MYBPC2	1.71e-04	891	67	11	GO:0005198
GeneOntologyBiologicalProcess	cholesterol biosynthetic process	ACLY ACAA2 APOB SEC14L2	5.93e-05	65	67	4	GO:0006695
GeneOntologyBiologicalProcess	secondary alcohol biosynthetic process	ACLY ACAA2 APOB SEC14L2	5.93e-05	65	67	4	GO:1902653
GeneOntologyBiologicalProcess	forebrain regionalization	EOMES FEZF2 ADGRG1	7.16e-05	25	67	3	GO:0021871
GeneOntologyBiologicalProcess	sterol biosynthetic process	ACLY ACAA2 APOB SEC14L2	8.86e-05	72	67	4	GO:0016126
GeneOntologyCellularComponent	euchromatin	MYC H1-3 H1-5 H1-1	8.42e-05	72	67	4	GO:0000791
GeneOntologyCellularComponent	cilium	SPTBN5 EPS15 DLG5 WDR11 MYO7A CETN3 ODAD1 DNAH17 CEP131 FHDC1 SLC25A31	1.23e-04	898	67	11	GO:0005929
GeneOntologyCellularComponent	ciliary transition zone	SPTBN5 MYO7A CETN3 CEP131	1.33e-04	81	67	4	GO:0035869
GeneOntologyCellularComponent	nuclear pore	RGPD8 CETN3 NUP133 RGPD5	3.12e-04	101	67	4	GO:0005643
GeneOntologyCellularComponent	spectrin	SPTBN5 SPTBN2	3.59e-04	9	67	2	GO:0008091
GeneOntologyCellularComponent	photoreceptor connecting cilium	SPTBN5 MYO7A CETN3	4.91e-04	48	67	3	GO:0032391
GeneOntologyCellularComponent	outer dynein arm	ODAD1 DNAH17	6.54e-04	12	67	2	GO:0036157
Domain	Histone_H5	H1-3 H1-5 H1-1	2.33e-06	8	66	3	IPR005819
Domain	H15	H1-3 H1-5 H1-1	1.18e-05	13	66	3	SM00526
Domain	Linker_histone	H1-3 H1-5 H1-1	1.18e-05	13	66	3	PF00538
Domain	H15	H1-3 H1-5 H1-1	1.18e-05	13	66	3	PS51504
Domain	Histone_H1/H5_H15	H1-3 H1-5 H1-1	1.49e-05	14	66	3	IPR005818
Domain	Actinin_actin-bd_CS	SPTBN5 SPTBN2 UTRN	7.10e-05	23	66	3	IPR001589
Domain	Spectrin	SPTBN5 SPTBN2 UTRN	7.10e-05	23	66	3	PF00435
Domain	ACTININ_2	SPTBN5 SPTBN2 UTRN	7.10e-05	23	66	3	PS00020
Domain	ACTININ_1	SPTBN5 SPTBN2 UTRN	7.10e-05	23	66	3	PS00019
Domain	Spectrin_repeat	SPTBN5 SPTBN2 UTRN	1.44e-04	29	66	3	IPR002017
Domain	Spectrin/alpha-actinin	SPTBN5 SPTBN2 UTRN	1.94e-04	32	66	3	IPR018159
Domain	SPEC	SPTBN5 SPTBN2 UTRN	1.94e-04	32	66	3	SM00150
Domain	-	EPS15 EPS15L1 CETN3 PLCH2 SPOCK2 UTRN	3.17e-04	261	66	6	1.10.238.10
Domain	PH_dom-spectrin-type	SPTBN5 SPTBN2	4.36e-04	9	66	2	IPR001605
Domain	EF-hand-dom_pair	EPS15 EPS15L1 CETN3 PLCH2 SPOCK2 UTRN	5.24e-04	287	66	6	IPR011992
Domain	EF-hand_4	EPS15 EPS15L1	5.43e-04	10	66	2	PF12763
Domain	Grip	RGPD8 RGPD5	6.63e-04	11	66	2	SM00755
Domain	EH	EPS15 EPS15L1	6.63e-04	11	66	2	PS50031
Domain	GRIP	RGPD8 RGPD5	6.63e-04	11	66	2	PF01465
Domain	EH	EPS15 EPS15L1	6.63e-04	11	66	2	SM00027
Domain	EH_dom	EPS15 EPS15L1	6.63e-04	11	66	2	IPR000261
Domain	PH_dom-like	SPTBN5 RGPD8 MYO7A PLCH2 SPTBN2 TLN2 RGPD5	7.47e-04	426	66	7	IPR011993
Domain	Ran_BP1	RGPD8 RGPD5	7.93e-04	12	66	2	PF00638
Domain	GRIP_dom	RGPD8 RGPD5	7.93e-04	12	66	2	IPR000237
Domain	GRIP	RGPD8 RGPD5	7.93e-04	12	66	2	PS50913
Domain	RANBD1	RGPD8 RGPD5	7.93e-04	12	66	2	PS50196
Domain	RanBD	RGPD8 RGPD5	9.36e-04	13	66	2	SM00160
Domain	Ran_bind_dom	RGPD8 RGPD5	9.36e-04	13	66	2	IPR000156
Domain	CH	SPTBN5 SPTBN2 UTRN	1.57e-03	65	66	3	SM00033
Domain	CH	SPTBN5 SPTBN2 UTRN	1.95e-03	70	66	3	PF00307
Domain	-	SPTBN5 SPTBN2 UTRN	2.03e-03	71	66	3	1.10.418.10
Domain	EF-hand_1	EPS15 EPS15L1 CETN3 PLCH2	2.05e-03	152	66	4	PF00036
Domain	CH	SPTBN5 SPTBN2 UTRN	2.20e-03	73	66	3	PS50021
Domain	EFh	EPS15 EPS15L1 CETN3 PLCH2	2.36e-03	158	66	4	SM00054
Domain	CH-domain	SPTBN5 SPTBN2 UTRN	2.37e-03	75	66	3	IPR001715
Domain	-	SPTBN5 RGPD8 MYO7A PLCH2 SPTBN2 TLN2	2.56e-03	391	66	6	2.30.29.30
Domain	EF_Hand_1_Ca_BS	EPS15 EPS15L1 CETN3 PLCH2	3.42e-03	175	66	4	IPR018247
Domain	-	DLG5 DAPK1 NLRP8	4.36e-03	93	66	3	1.10.533.10
Domain	DEATH-like_dom	DLG5 DAPK1 NLRP8	5.19e-03	99	66	3	IPR011029
Domain	EF_HAND_1	EPS15 EPS15L1 CETN3 PLCH2	5.87e-03	204	66	4	PS00018
Domain	FERM_N	MYO7A TLN2	6.05e-03	33	66	2	PF09379
Domain	FERM_N	MYO7A TLN2	6.05e-03	33	66	2	IPR018979
Pathway	REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF	LMNB1 H1-3 H1-5 H1-1	3.49e-07	17	51	4	M27189
Pathway	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION	H1-3 H1-5 H1-1	1.24e-05	13	51	3	M1018
Pathway	REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF	LMNB1 H1-5 H1-1	1.97e-05	15	51	3	MM14902
Pathway	REACTOME_APOPTOTIC_EXECUTION_PHASE	LMNB1 H1-3 H1-5 H1-1	3.62e-05	52	51	4	M2341
Pathway	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	SPTBN5 COL6A1 SPTBN2 GFRA1	7.73e-05	63	51	4	M11187
Pathway	REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE	LMNB1 H1-3 H1-5 H1-1	1.87e-04	79	51	4	M27191
Pathway	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	SPTBN5 COL6A1 SPTBN2	3.44e-04	38	51	3	MM14969
Pathway	WP_BLADDER_CANCER	MYC PIK3R2 DAPK1	4.01e-04	40	51	3	M39523
Pathway	WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES	EPS15 EPS15L1 DENND1B PIK3C2A ACLY ACAA2 APOB	4.14e-04	381	51	7	M48063
Pathway	REACTOME_APOPTOSIS	LMNB1 H1-3 H1-5 DAPK1 H1-1	4.57e-04	179	51	5	M15303
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	EPS15 EPS15L1 STRN4 LMTK2 CPSF1 CEP131 UTRN	4.75e-09	125	67	7	29467281
Pubmed	Chromatin condensing functions of the linker histone C-terminal domain are mediated by specific amino acid composition and intrinsic protein disorder.	H1-3 H1-5 H1-1	2.73e-08	4	67	3	19072710
Pubmed	Expression of murine H1 histone genes during postnatal development.	H1-3 H1-5 H1-1	6.81e-08	5	67	3	9655912
Pubmed	The mouse histone H1 genes: gene organization and differential regulation.	H1-3 H1-5 H1-1	6.81e-08	5	67	3	9300059
Pubmed	A compendium of the histone H1 family of somatic subtypes: an elusive cast of characters and their characteristics.	H1-3 H1-5 H1-1	6.81e-08	5	67	3	11467742
Pubmed	A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences.	H1-3 H1-5 H1-1	6.81e-08	5	67	3	8003976
Pubmed	The preferential binding of histone H1 to DNA scaffold-associated regions is determined by its C-terminal domain.	H1-3 H1-5 H1-1	1.36e-07	6	67	3	15562002
Pubmed	Linker histone transitions during mammalian oogenesis and embryogenesis.	H1-3 H1-5 H1-1	1.36e-07	6	67	3	9499577
Pubmed	H1 family histones in the nucleus. Control of binding and localization by the C-terminal domain.	H1-3 H1-5 H1-1	1.36e-07	6	67	3	15911621
Pubmed	Characterization of phosphorylation sites on histone H1 isoforms by tandem mass spectrometry.	H1-3 H1-5 H1-1	1.36e-07	6	67	3	15595731
Pubmed	The multifunctional protein nucleophosmin (NPM1) is a human linker histone H1 chaperone.	H1-3 H1-5 H1-1	1.36e-07	6	67	3	21425800
Pubmed	Hormone-mediated dephosphorylation of specific histone H1 isoforms.	H1-3 H1-5 H1-1	1.36e-07	6	67	3	11479299
Pubmed	Histone H1 subtype preferences of DFF40 and possible nuclear localization of DFF40/45 in normal and trichostatin A-treated NB4 leukemic cells.	H1-3 H1-5 H1-1	1.36e-07	6	67	3	19882353
Pubmed	All known human H1 histone genes except the H1(0) gene are clustered on chromosome 6.	H1-3 H1-5 H1-1	2.38e-07	7	67	3	8325638
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MYC DIS3L2 LMNB1 WDR11 PIK3C2A ACLY H1-5 NUP133 CPSF1 GEMIN5 H1-1 ACAA2 UTRN SLC3A2	2.41e-07	1353	67	14	29467282
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RGPD8 LMNB1 STRBP SPTBN2 H1-3 STRN4 H1-5 RBM5 H1-1 APOB SLC25A31 SLC3A2 RGPD5 MYBPC2	5.19e-07	1442	67	14	35575683
Pubmed	Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms.	EPS15 EPS15L1 PIK3R2 H1-3 H1-1 APOB SLC3A2	6.44e-07	256	67	7	24189400
Pubmed	Dynamic changes in H1 subtype composition during epigenetic reprogramming.	H1-3 H1-5 H1-1	8.12e-07	10	67	3	28794128
Pubmed	High-throughput kinase assays with protein substrates using fluorescent polymer superquenching.	H1-3 H1-5 H1-1	8.12e-07	10	67	3	15927069
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	EPS15L1 LMNB1 ACLY SPTBN2 CAST STRN4 GEMIN5 SLC3A2 RGPD5	1.08e-06	549	67	9	38280479
Pubmed	Role of H1 linker histones in mammalian development and stem cell differentiation.	H1-3 H1-5 H1-1	1.12e-06	11	67	3	26689747
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	COL6A1 EPS15 RGPD8 ZNF532 LCORL GEMIN5 CEP131 UTRN	1.43e-06	418	67	8	34709266
Pubmed	A unified phylogeny-based nomenclature for histone variants.	H1-3 H1-5 H1-1	1.48e-06	12	67	3	22650316
Pubmed	Characterization of the mouse histone gene cluster on chromosome 13: 45 histone genes in three patches spread over 1Mb.	H1-3 H1-5 H1-1	1.93e-06	13	67	3	8858344
Pubmed	alphaII-betaV spectrin bridges the plasma membrane and cortical lattice in the lateral wall of the auditory outer hair cells.	SPTBN5 MYO7A SPTBN2	1.93e-06	13	67	3	18796539
Pubmed	Defining the membrane proteome of NK cells.	EPS15 EPS15L1 LMNB1 WDR11 PIK3C2A ERAP1 ACLY NUP133 GEMIN5 BZW1 MCTP2 SLC3A2	2.12e-06	1168	67	12	19946888
Pubmed	Identification of QTL genes for BMD variation using both linkage and gene-based association approaches.	ERAP1 CAST	3.66e-06	2	67	2	21424381
Pubmed	CRL4DCAF8 dependent opposing stability control over the chromatin remodeler LSH orchestrates epigenetic dynamics in ferroptosis.	H1-3 H1-5 H1-1	3.76e-06	16	67	3	33288900
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	STRBP ACLY SPTBN2 H1-3 NUP133 CPSF1 GEMIN5 H1-1 UTRN	4.45e-06	653	67	9	22586326
Pubmed	Vti1b promotes TRPV1 sensitization during inflammatory pain.	COL6A1 MYO7A VWA5A ACLY H1-3	4.83e-06	127	67	5	30335684
Pubmed	Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease.	SPTBN5 SPTBN2 TLN2	5.46e-06	18	67	3	12119179
Pubmed	Myc binds the pluripotency factor Utf1 through the basic-helix-loop-helix leucine zipper domain.	MYC H1-5 H1-1	6.48e-06	19	67	3	23665319
Pubmed	A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins.	EPS15 EPS15L1	1.10e-05	3	67	2	11919637
Pubmed	Differential patterns of expression of Eps15 and Eps15R during mouse embryogenesis.	EPS15 EPS15L1	1.10e-05	3	67	2	10906484
Pubmed	Mouse p170 is a novel phosphatidylinositol 3-kinase containing a C2 domain.	PIK3C2A PIK3R2	1.10e-05	3	67	2	8663140
Pubmed	Human spleen histone H1. Isolation and amino acid sequences of three minor variants, H1a, H1c, and H1d.	H1-3 H1-5	1.10e-05	3	67	2	2613692
Pubmed	The C-terminal domain (CTD) in linker histones antagonizes anti-apoptotic proteins to modulate apoptotic outcomes at the mitochondrion.	H1-3 H1-1	1.10e-05	3	67	2	24525734
Pubmed	Regulation of calpain activity by c-Myc through calpastatin and promotion of transformation in c-Myc-negative cells by calpastatin suppression.	MYC CAST	1.10e-05	3	67	2	18544539
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	MED24 EPS15 WDR11 ACLY STRN4 NUP133 ACAA2 BZW1	1.22e-05	560	67	8	35241646
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	EPS15 DLG5 EPS15L1 SPTBN2 CAST BZW1 UTRN SLC3A2	1.30e-05	565	67	8	25468996
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	DLG5 LMNB1 ACLY SPTBN2 H1-3 H1-5 CPSF1 APOB MCTP2 SLC3A2	1.32e-05	949	67	10	36574265
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	EPS15 EPS15L1 LMNB1 WDR11 RBM5 CEP131 APOB ANO3 SLC3A2	1.78e-05	777	67	9	35844135
Pubmed	Proximity interactions of the ubiquitin ligase Mind bomb 1 reveal a role in regulation of epithelial polarity complex proteins.	EPS15 EPS15L1 RGPD8 GEMIN5 CEP131	1.93e-05	169	67	5	31462741
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	LMNB1 H1-5 NUP133 CPSF1 GEMIN5 SPOCK2 BZW1 SLC3A2	2.17e-05	607	67	8	39147351
Pubmed	MSX1 cooperates with histone H1b for inhibition of transcription and myogenesis.	H1-5 H1-1	2.19e-05	4	67	2	15192231
Pubmed	Discovery of a diaminoquinoxaline benzenesulfonamide antagonist of HIV-1 Nef function using a yeast-based phenotypic screen.	PIK3R2 ZAP70	2.19e-05	4	67	2	24229420
Pubmed	Structure of the Eps15-stonin2 complex provides a molecular explanation for EH-domain ligand specificity.	EPS15 EPS15L1	2.19e-05	4	67	2	18200045
Pubmed	Eps15R is a tyrosine kinase substrate with characteristics of a docking protein possibly involved in coated pits-mediated internalization.	EPS15 EPS15L1	2.19e-05	4	67	2	9446614
Pubmed	Distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin II: distribution in human adult fibroblasts.	H1-3 H1-5	2.19e-05	4	67	2	11746507
Pubmed	The distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin: distribution in human fetal fibroblasts.	H1-3 H1-5	2.19e-05	4	67	2	10997781
Pubmed	Zap70 functions to maintain stemness of mouse embryonic stem cells by negatively regulating Jak1/Stat3/c-Myc signaling.	MYC ZAP70	2.19e-05	4	67	2	20641039
Pubmed	Isolation of two murine H1 histone genes and chromosomal mapping of the H1 gene complement.	H1-3 H1-5	2.19e-05	4	67	2	8589518
Pubmed	The eps15 homology (EH) domain-based interaction between eps15 and hrb connects the molecular machinery of endocytosis to that of nucleocytosolic transport.	EPS15 EPS15L1	2.19e-05	4	67	2	10613896
Pubmed	Identification of a novel Ran binding protein 2 related gene (RANBP2L1) and detection of a gene cluster on human chromosome 2q11-q12.	RGPD8 RGPD5	2.19e-05	4	67	2	9480752
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MED24 EPS15 DLG5 WDR11 PIK3C2A STRN4 RBM5 ADGRG1 GEMIN5 CEP131 UTRN SLC3A2	2.58e-05	1497	67	12	31527615
Pubmed	Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.	MED24 H1-3 H1-5 H1-1	2.60e-05	88	67	4	26318153
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	MYC RGPD8 LMNB1 WDR11 ACLY H1-3 NUP133 CPSF1 H1-1 SLC3A2 RGPD5	2.64e-05	1257	67	11	37317656
Pubmed	MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.	LMNB1 ERAP1 ACLY CAST SLC3A2	2.76e-05	182	67	5	30711629
Pubmed	The giant spectrin βV couples the molecular motors to phototransduction and Usher syndrome type I proteins along their trafficking route.	SPTBN5 MYO7A SPTBN2	3.26e-05	32	67	3	23704327
Pubmed	EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas.	EPS15 EPS15L1	3.64e-05	5	67	2	18395097
Pubmed	Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.	ERAP1 CAST	3.64e-05	5	67	2	22286212
Pubmed	The clathrin adaptor Dab2 recruits EH domain scaffold proteins to regulate integrin β1 endocytosis.	EPS15 EPS15L1	3.64e-05	5	67	2	22648170
Pubmed	Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein.	H1-3 H1-1	3.64e-05	5	67	2	10893414
Pubmed	Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis.	EPS15 EPS15L1	3.64e-05	5	67	2	9723620
Pubmed	The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R.	EPS15 EPS15L1	3.64e-05	5	67	2	7797522
Pubmed	Ubiquilin recruits Eps15 into ubiquitin-rich cytoplasmic aggregates via a UIM-UBL interaction.	EPS15 EPS15L1	3.64e-05	5	67	2	16159959
Pubmed	DDB1 binds histone reader BRWD3 to activate the transcriptional cascade in adipogenesis and promote onset of obesity.	MED24 WDR11 H1-5 H1-1	4.13e-05	99	67	4	34161765
Pubmed	Human histone gene organization: nonregular arrangement within a large cluster.	H1-3 H1-5 H1-1	4.28e-05	35	67	3	9119399
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	EPS15L1 MYO7A ZNF827 STRN4 LMTK2 CPSF1 GEMIN5 TLN2 CEP131 MAST2	4.83e-05	1105	67	10	35748872
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	PIK3C2A NUP133 RBM5 ACAA2 MAST2 UTRN MYBPC2	4.84e-05	497	67	7	23414517
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	MED24 LMNB1 STRBP H1-3 H1-5 ACAA2 SLC3A2	5.22e-05	503	67	7	36217030
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	EPS15 EPS15L1 NUP133 GEMIN5 TLN2 CEP131 BZW1	5.22e-05	503	67	7	16964243
Pubmed	Characterization of G protein-coupled receptor 56 protein expression in the mouse developing neocortex.	EOMES ADGRG1	5.46e-05	6	67	2	22351047
Pubmed	Conditional deletion of N-Myc disrupts neurosensory and non-sensory development of the ear.	MYC MYO7A	5.46e-05	6	67	2	21448975
Pubmed	ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1.	MYC CPSF1	5.46e-05	6	67	2	37040401
Pubmed	Demonstration of in vitro interaction between tumor suppressor lysyl oxidase and histones H1 and H2: definition of the regions involved.	H1-5 H1-1	5.46e-05	6	67	2	12686141
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	DLG5 EPS15L1 WDR11 NUP133 GEMIN5	6.23e-05	216	67	5	31519766
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	EPS15 EPS15L1 ACLY PIK3R2 RBM5 CPSF1 UTRN SLC25A31 SLC3A2	6.39e-05	916	67	9	32203420
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	EPS15 EPS15L1 RGPD8 LMNB1 CETN3 STRN4 NUP133 TLN2 CEP131 RGPD5	6.98e-05	1155	67	10	20360068
Pubmed	Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.	H1-3 H1-5	7.63e-05	7	67	2	24435047
Pubmed	Cloning and characterization of RLPK, a novel RSK-related protein kinase.	H1-5 H1-1	7.63e-05	7	67	2	9873047
Pubmed	A multimodal cell census and atlas of the mammalian primary motor cortex.	EOMES FEZF2	7.63e-05	7	67	2	34616075
Pubmed	Complex genomic rearrangements lead to novel primate gene function.	RGPD8 RGPD5	7.63e-05	7	67	2	15710750
Pubmed	Genome-wide association study of alcohol dependence.	ERAP1 CAST	7.63e-05	7	67	2	19581569
Pubmed	c-MYC-USP49-BAG2 axis promotes proliferation and chemoresistance of colorectal cancer cells in vitro.	MYC CETN3	7.63e-05	7	67	2	35367823
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	LMNB1 ACLY NUP133 RBM5 CPSF1 GEMIN5 TLN2 APOB BZW1 MAST2 SLC3A2	8.19e-05	1425	67	11	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	EPS15L1 MYO7A ACLY SPTBN2 H1-3 STRN4 GEMIN5 DAPK1 TLN2 UTRN SLC3A2	8.50e-05	1431	67	11	37142655
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	EPS15L1 RGPD8 LMNB1 H1-3 H1-5	8.55e-05	231	67	5	16452087
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	WDR11 PIK3C2A RBM5 GEMIN5 MAST2	8.72e-05	232	67	5	25515538
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	EPS15 EPS15L1 RGPD8 LMNB1 SPTBN2 STRN4 DAPK1 TLN2 CEP131	9.35e-05	963	67	9	28671696
Pubmed	Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration.	EPS15L1 UTRN SLC3A2	9.78e-05	46	67	3	35022314
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	EPS15 EPS15L1 LMNB1 ACLY CAST STRN4 H1-5 NUP133 GEMIN5 ACAA2 BZW1	9.85e-05	1455	67	11	22863883
Pubmed	Substrate specificity and activity regulation of protein kinase MELK.	LMNB1 H1-5	1.02e-04	8	67	2	16216881
Pubmed	Apolipoprotein B is a new target of the GDNF/RET and ET-3/EDNRB signalling pathways.	APOB GFRA1	1.02e-04	8	67	2	22897442
Pubmed	Stonin 2: an adaptor-like protein that interacts with components of the endocytic machinery.	EPS15 EPS15L1	1.02e-04	8	67	2	11381094
Pubmed	The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation.	PIK3R2 ZAP70	1.02e-04	8	67	2	11133830
Pubmed	Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.	RGPD8 ZAP70	1.02e-04	8	67	2	28745977
Pubmed	A novel chromatin protein, distantly related to histone H2A, is largely excluded from the inactive X chromosome.	H1-5 H1-1	1.02e-04	8	67	2	11266453
Pubmed	PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.	EPS15 PIK3R2 H1-3 CEP131 SLC3A2	1.17e-04	247	67	5	32989298
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EPS15 EPS15L1 DENND1B ZNF532 WDR11 ZNF827 CAST RBM5 ADGRG1 MCTP2 UTRN	1.21e-04	1489	67	11	28611215
GeneFamily	EF-hand domain containing\|Spectrins	SPTBN5 SPTBN2	1.56e-04	7	50	2	1113
Coexpression	GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN	EOMES EPS15 CAST ADGRG1 MCTP2 UTRN	1.24e-05	200	67	6	M4656
Coexpression	GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP	EPS15L1 DENND1B PIK3C2A VWA5A DAPK1 MYBPC2	1.24e-05	200	67	6	M6664
Coexpression	GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN	NPL MED24 LMNB1 H1-1 ACAA2 FHDC1	1.24e-05	200	67	6	M7134
CoexpressionAtlas	gamma delta T cells, Tgd.vg1+vd6-.Th.TCRbko, TCRd+ Vg1.1+, Thymus, avg-3	EOMES H1-5 H1-1 ZAP70 GFRA1	4.69e-06	79	66	5	GSM605784_100
CoexpressionAtlas	alpha beta T cells, T.8SP24-.Th, 4- 8+ TCRhi 24-/lo, Thymus, avg-3	EOMES MYC ZNF827 H1-5 H1-1 MCTP2 UTRN ZAP70	1.28e-05	351	66	8	GSM399379_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg1+vd6-.Th.TCRbko, TCRd+ Vg1.1+, Thymus, avg-3	EOMES MED24 LMNB1 H1-5 SPOCK2 H1-1 ZAP70 GFRA1	1.60e-05	362	66	8	GSM605784_500
CoexpressionAtlas	B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3	LMNB1 MYO7A STRBP H1-5 ADGRG1 H1-1 MCTP2 GFRA1	2.99e-05	395	66	8	GSM538340_500
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2	MYC NPL LMNB1 H1-5 ADGRG1 H1-1 MCTP2 GFRA1	3.21e-05	399	66	8	GSM538345_500
CoexpressionAtlas	alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3	LMNB1 STRBP H1-5 NUP133 ADGRG1 H1-1 ZAP70 GFRA1	4.39e-05	417	66	8	GSM399403_500
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1	MYC NPL LMNB1 STRBP H1-5 ADGRG1 H1-1 GFRA1	4.46e-05	418	66	8	GSM538350_500
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2	MYC NPL LMNB1 STRBP H1-5 ADGRG1 H1-1 GFRA1	4.54e-05	419	66	8	GSM538348_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2	EOMES LMNB1 H1-5 ADGRG1 H1-1 UTRN ZAP70 GFRA1	4.77e-05	422	66	8	GSM476658_500
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1	MYC NPL LMNB1 STRBP H1-5 ADGRG1 H1-1 GFRA1	4.77e-05	422	66	8	GSM538357_500
CoexpressionAtlas	B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1	H1-5 ADGRG1 H1-1 GFRA1	8.32e-05	74	66	4	GSM538418_100
CoexpressionAtlas	Stem Cells, SC.GMP.BM, Lineage- sca1- ckithi CD34+ FcgRhi, Bone marrow, avg-3	NPL H1-5 ADGRG1 H1-1	1.18e-04	81	66	4	GSM791119_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3	EOMES H1-5 H1-1 ZAP70	1.30e-04	83	66	4	GSM538387_100
CoexpressionAtlas	gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3	H1-5 H1-1 ZAP70 GFRA1	1.36e-04	84	66	4	GSM476675_100
CoexpressionAtlas	B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2	H1-5 ADGRG1 H1-1 GFRA1	1.43e-04	85	66	4	GSM399450_100
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3	H1-5 H1-1 ZAP70 GFRA1	1.43e-04	85	66	4	GSM605793_100
CoexpressionAtlas	B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3	H1-5 ADGRG1 H1-1 GFRA1	1.43e-04	85	66	4	GSM538358_100
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000	DLG5 DENND1B PIK3C2A DAPK1 ACAA2 UTRN	1.53e-04	259	66	6	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_1000
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_200	MYO7A ACLY PIWIL4 ACAA2 SLC25A31	1.54e-04	163	66	5	gudmap_developingGonad_e16.5_testes_200
CoexpressionAtlas	alpha beta T cells, preT.DN3B.Th, Lin-/lo CD25hi CD44- CD28+, Thymus, avg-3	H1-5 ADGRG1 H1-1 GFRA1	1.56e-04	87	66	4	GSM791149_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3	EOMES LMNB1 H1-5 H1-1 MCTP2 UTRN ZAP70	1.59e-04	374	66	7	GSM538389_500
CoexpressionAtlas	B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1	LMNB1 STRBP H1-5 ADGRG1 H1-1 MCTP2 GFRA1	1.64e-04	376	66	7	GSM538418_500
CoexpressionAtlas	B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2	H1-5 ADGRG1 H1-1 GFRA1	1.70e-04	89	66	4	GSM538352_100
CoexpressionAtlas	B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3	LMNB1 STRBP H1-5 ADGRG1 H1-1 MCTP2 GFRA1	1.83e-04	383	66	7	GSM399448_500
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000	MYO7A LCORL ACLY NUP133 RBM5 ADGRG1 DAPK1 ACAA2 MAST2 SLC25A31	2.06e-04	819	66	10	gudmap_developingGonad_e12.5_testes_1000
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000	MYO7A ACLY NUP133 ADGRG1 GEMIN5 PIWIL4 DAPK1 ACAA2 MAST2 SLC25A31	2.06e-04	819	66	10	gudmap_developingGonad_e16.5_testes_1000
CoexpressionAtlas	alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3	MYC H1-5 NUP133 ADGRG1 H1-1 ZAP70 GFRA1	2.28e-04	397	66	7	GSM791143_500
CoexpressionAtlas	alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3	LMNB1 STRBP H1-5 ADGRG1 H1-1 MAST2 ZAP70	2.32e-04	398	66	7	GSM399397_500
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000	DLG5 DENND1B ZNF532 PIK3C2A ZNF827 ADGRG1 DAPK1 ACAA2 MAST2 UTRN	2.45e-04	837	66	10	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1	MYC LMNB1 STRBP ADGRG1 H1-1 MCTP2 GFRA1	2.58e-04	405	66	7	GSM538343_500
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_500	MYO7A ACLY NUP133 ADGRG1 PIWIL4 ACAA2 SLC25A31	2.74e-04	409	66	7	gudmap_developingGonad_e16.5_testes_500
CoexpressionAtlas	alpha beta T cells, preT.DN3B.Th, Lin-/lo CD25hi CD44- CD28+, Thymus, avg-3	MYC H1-5 NUP133 ADGRG1 H1-1 ZAP70 GFRA1	2.90e-04	413	66	7	GSM791149_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3	EOMES DLG5 LMNB1 H1-5 TLN2 H1-1 ZAP70	3.17e-04	419	66	7	GSM476664_500
CoexpressionAtlas	alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1	EOMES COL6A1 ZNF827 MCTP2 UTRN ZAP70	3.20e-04	297	66	6	GSM538414_500
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2	NPL LMNB1 STRBP H1-5 ADGRG1 H1-1 GFRA1	3.31e-04	422	66	7	GSM538355_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3	LMNB1 ZNF827 H1-5 H1-1 UTRN ZAP70 GFRA1	3.35e-04	423	66	7	GSM476655_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_1000	EPS15 LCORL GEMIN5 SLC25A31	3.45e-04	107	66	4	gudmap_developingGonad_e16.5_ovary_1000_k4
CoexpressionAtlas	alpha beta T cells, T.8Mem.LN, CD8 TCRb CD44high CD122high, Lymph Node, avg-3	EOMES MYC DLG5 ZNF827 MCTP2 ZAP70	5.50e-04	329	66	6	GSM538395_500
CoexpressionAtlas	alpha beta T cells, T.8Nve.LN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3	EOMES MYC ZNF827 MCTP2 UTRN ZAP70	5.95e-04	334	66	6	GSM538406_500
CoexpressionAtlas	alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1	EOMES ZNF827 ACAA2 MCTP2 UTRN ZAP70	6.14e-04	336	66	6	GSM538413_500
CoexpressionAtlas	B cells, proB.CLP.BM, AA4.1+ CD117+ IL7R+ CD45R- CD24- CD19- IgM-, Bone marrow, avg-1	NPL STRBP H1-5 ADGRG1 H1-1 GFRA1	6.33e-04	338	66	6	GSM538347_500
CoexpressionAtlas	alpha beta T cells, T.4Mem.Sp, 4+ 8- 25- 44hi 122lo, Spleen, avg-3	EOMES ZNF827 H1-5 SPOCK2 UTRN ZAP70	6.84e-04	343	66	6	GSM538365_500
CoexpressionAtlas	alpha beta T cells, T.8Nve.Sp, 4- 8+ 25- 62Lhi 44lo, Spleen, avg-3	EOMES KCNC1 ZNF827 MCTP2 UTRN ZAP70	8.06e-04	354	66	6	GSM538415_500
CoexpressionAtlas	alpha beta T cells, T.8Nve.MLN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3	EOMES MYC ZNF827 MCTP2 UTRN ZAP70	8.30e-04	356	66	6	GSM538409_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_100	LCORL SLC25A31	8.45e-04	14	66	2	gudmap_developingGonad_e12.5_ovary_k3_100
CoexpressionAtlas	alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2	EOMES LMNB1 H1-5 ADGRG1 H1-1 ZAP70	8.67e-04	359	66	6	GSM605773_500
CoexpressionAtlas	alpha beta T cells, T.4Mem44h62l.Sp, CD4 TCRb CD44hi CD62Llo, Spleen, avg-3	EOMES ZNF827 SPOCK2 MCTP2 UTRN ZAP70	8.67e-04	359	66	6	GSM538371_500
CoexpressionAtlas	DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000	COL6A1 MYO7A ACLY NUP133 ADGRG1 SPOCK2 ACAA2 MAST2 SLC25A31	8.93e-04	814	66	9	gudmap_developingGonad_e18.5_testes_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000	MYO7A ACLY NUP133 ADGRG1 GEMIN5 PIWIL4 ACAA2 MAST2 SLC25A31	9.57e-04	822	66	9	gudmap_developingGonad_e14.5_ testes_1000
CoexpressionAtlas	alpha beta T cells, T.DP.Th, 4+ 8+ TCR-/lo 69-, Thymus, avg-3	LMNB1 H1-5 ADGRG1 DAPK1 H1-1 ZAP70	9.71e-04	367	66	6	GSM399391_500
CoexpressionAtlas	B cells, B.FrE.FL, AA4.1+ IgM+ CD19+ CD43- CD24+, Fetal Liver, avg-3	MYO7A STRBP H1-5 H1-1 MCTP2 GFRA1	1.04e-03	372	66	6	GSM538204_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_500	LCORL GEMIN5 SLC25A31	1.04e-03	64	66	3	gudmap_developingGonad_e16.5_ovary_500_k2
CoexpressionAtlas	gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3	EOMES LMNB1 H1-5 H1-1 ZAP70 GFRA1	1.06e-03	373	66	6	GSM605781_500
CoexpressionAtlas	alpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3	H1-5 NUP133 ADGRG1 H1-1 ZAP70 GFRA1	1.10e-03	376	66	6	GSM791154_500
CoexpressionAtlas	B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2	LMNB1 H1-5 ADGRG1 H1-1 MCTP2 GFRA1	1.29e-03	388	66	6	GSM538352_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3	EOMES KCNC1 ZNF827 UTRN ZAP70 GFRA1	1.29e-03	388	66	6	GSM605790_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg1+vd6+.Th.TCRbko, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-3	H1-5 H1-1 ZAP70	1.41e-03	71	66	3	GSM605778_100
CoexpressionAtlas	B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1	STRBP H1-5 ADGRG1 H1-1 MCTP2 GFRA1	1.42e-03	395	66	6	GSM538351_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-24ahi.Th.TCRbko, TCRd+ Vg2- CD24+, Thymus, avg-3	EOMES ZNF827 H1-5 SPOCK2 H1-1 ZAP70	1.43e-03	396	66	6	GSM605799_500
CoexpressionAtlas	B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3	LMNB1 STRBP H1-5 ADGRG1 H1-1 GFRA1	1.51e-03	400	66	6	GSM538358_500
CoexpressionAtlas	NK cells, NK.MCMV1.Sp, CD3-,NK1.1+, Spleen, avg-3	EOMES MCTP2 ZAP70	1.53e-03	73	66	3	GSM538309_100
CoexpressionAtlas	B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2	LMNB1 STRBP H1-5 ADGRG1 H1-1 GFRA1	1.53e-03	401	66	6	GSM399450_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3	EOMES LMNB1 H1-5 H1-1 MCTP2 ZAP70	1.55e-03	402	66	6	GSM605898_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3	EOMES KCNC1 ZNF827 SPOCK2 UTRN ZAP70	1.61e-03	405	66	6	GSM605796_500
CoexpressionAtlas	gudmap_RNAseq_e15.5_Mesangium_2500_K4	SPOCK2 ACAA2 MCTP2 GFRA1	1.63e-03	162	66	4	gudmap_RNAseq_e15.5_Mesangium_2500_K4
CoexpressionAtlas	NK cells, NK.H+.MCMV1.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3	EOMES MCTP2 ZAP70	1.65e-03	75	66	3	GSM538300_100
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_500	MYO7A ACLY ADGRG1 SPOCK2 ACAA2 SLC25A31	1.67e-03	408	66	6	gudmap_developingGonad_P2_testes_500
CoexpressionAtlas	B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3	LMNB1 STRBP H1-5 ADGRG1 H1-1 GFRA1	1.69e-03	409	66	6	GSM399452_500
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500	MYO7A ACLY ADGRG1 PIWIL4 ACAA2 SLC25A31	1.73e-03	411	66	6	gudmap_developingGonad_e14.5_ testes_500
CoexpressionAtlas	Stem Cells, SC.ST34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34+, Bone marrow, avg-2	MYC NPL STRBP H1-5 ADGRG1 H1-1	1.73e-03	411	66	6	GSM791112_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3	LMNB1 H1-5 ADGRG1 H1-1 ZAP70 GFRA1	1.75e-03	412	66	6	GSM605793_500
CoexpressionAtlas	DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_500	MYO7A ACLY ADGRG1 SPOCK2 ACAA2 SLC25A31	1.75e-03	412	66	6	gudmap_developingGonad_e18.5_testes_500
CoexpressionAtlas	alpha beta T cells, T.DP.Th, 4+ 8+ TCR-/lo 69-, Thymus, avg-3	H1-5 H1-1 ZAP70	1.78e-03	77	66	3	GSM399391_100
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3	LMNB1 H1-5 ADGRG1 H1-1 ZAP70 GFRA1	1.80e-03	414	66	6	GSM476660_500
CoexpressionAtlas	alpha beta T cells, preT.ETP.Th, Lin-/lo CD25- CD44+ cKit+, Thymus, avg-3	MYC NPL H1-5 ADGRG1 H1-1 GFRA1	1.82e-03	415	66	6	GSM854335_500
CoexpressionAtlas	alpha beta T cells, preT.DN3A.Th, Lin-/lo CD25hi CD44- CD28-, Thymus, avg-3	MYC MED24 ADGRG1 DAPK1 H1-1 GFRA1	1.84e-03	416	66	6	GSM791146_500
ToppCell	COVID-NK-\|COVID / Condition, Cell_class and T cell subcluster	EOMES DLG5 PLCH2 ADGRG1 MCTP2 UTRN ZAP70	1.40e-08	188	67	7	fabdd68a9734d35e75e1f4a4bfd5c531cfc099f1
ToppCell	COVID-NK\|COVID / Condition, Cell_class and T cell subcluster	EOMES DLG5 PLCH2 ADGRG1 MCTP2 UTRN ZAP70	1.40e-08	188	67	7	0beaa671611110a11e46156f54f5202cc24967a4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC35F3 DNAH17 DAPK1 SPOCK2 MCTP2 UTRN	2.69e-07	176	67	6	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	mild_COVID-19_(asymptomatic)-gd_T\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	EOMES H1-3 ADGRG1 SPOCK2 MCTP2 ZAP70	3.73e-07	186	67	6	5fa3ed834898aa06aae15a8ade7ab93a6e4744f8
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EOMES H1-3 ADGRG1 MCTP2 UTRN ZAP70	3.85e-07	187	67	6	0bca79cea4886b66350c56c61859bd71e1e7a85c
ToppCell	COVID-19_Severe-NK_activated\|World / disease group, cell group and cell class	H1-3 H1-5 ADGRG1 MCTP2 UTRN ZAP70	5.22e-07	197	67	6	a60db36d1a192998e3ded63e0c7c08d41689f95f
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EOMES H1-3 ADGRG1 MCTP2 UTRN ZAP70	5.37e-07	198	67	6	0e918e9db9b884f5328d438e90efe065e27266ee
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EOMES H1-3 ADGRG1 MCTP2 UTRN ZAP70	5.37e-07	198	67	6	ce92d5fbc2eac27fb246b044fb1914ab92506275
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	EOMES H1-3 ADGRG1 MCTP2 UTRN ZAP70	5.37e-07	198	67	6	fed823d6e684d113bcc9ff3cd1803bb001aa02fa
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	EOMES H1-3 ADGRG1 MCTP2 UTRN ZAP70	5.37e-07	198	67	6	1ef3a6bd681c223eed58300348adfef89df5563c
ToppCell	COVID-19_Severe-Lymphoid_T/NK-NK_activated\|COVID-19_Severe / Disease group, lineage and cell class	EOMES H1-3 ADGRG1 MCTP2 UTRN ZAP70	5.54e-07	199	67	6	edf5f80b4c299e6bf462675f2cd3329d86c923d8
ToppCell	COVID-19_Severe-NK_activated\|COVID-19_Severe / disease group, cell group and cell class	EOMES H1-3 ADGRG1 MCTP2 UTRN ZAP70	5.54e-07	199	67	6	bda28d975f4017ec5bded1d3c72310eabc5aac07
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)---L5-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SPTBN5 FEZF2 VWA5A PIWIL4 MCTP2 GFRA1	5.70e-07	200	67	6	046a3a4d7e4d84ee4252a695ffd4a6aee8b77070
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SPTBN5 FEZF2 VWA5A PIWIL4 MCTP2 GFRA1	5.70e-07	200	67	6	893cc7f6b9794da90aa0c9d721b8647dc97201cd
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SPTBN5 FEZF2 VWA5A PIWIL4 MCTP2 GFRA1	5.70e-07	200	67	6	3d677f13e429abc805a52ec2b8f36c703f511569
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SPTBN5 FEZF2 VWA5A PIWIL4 MCTP2 GFRA1	5.70e-07	200	67	6	12518f4a8d01fc66b72878cdf0ba124b37cff3d8
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B\|367C / Donor, Lineage, Cell class and subclass (all cells)	EOMES H1-5 ADGRG1 MCTP2 ZAP70	4.45e-06	161	67	5	f7dc1e3326ab22f2eb1e94b632469a0682a3289c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SPTBN5 VWA5A PIWIL4 MCTP2 GFRA1	5.17e-06	166	67	5	739dfbe927f409821ff23aca6e47ebe78f57e859
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VWA5A PIWIL4 MCTP2 UTRN GFRA1	5.32e-06	167	67	5	a6ff7a3d9b80839c0efa91658836812e868561fa
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES MYO7A PLCH2 ADGRG1 MCTP2	5.48e-06	168	67	5	b4bb03efb601a61465260f93896c56861c588bef
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SPTBN5 FEZF2 VWA5A PIWIL4 MCTP2	5.48e-06	168	67	5	217770a94ace446cdfc7687b459dece707576e76
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES MYO7A PLCH2 ADGRG1 MCTP2	5.48e-06	168	67	5	240ea32b64d86f9216785010d6b237d9adf052c9
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SPTBN5 FEZF2 PIWIL4 MCTP2 ANO3	5.64e-06	169	67	5	716e9d4c5fb99c56b76afaa5ed90bfa859fde802
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES MYO7A PLCH2 ADGRG1 MCTP2	5.64e-06	169	67	5	e7470a5b060881b2a8ce2ab04b0788396aa13889
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SPTBN5 VWA5A PIWIL4 MCTP2 GFRA1	5.80e-06	170	67	5	84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES MYO7A PLCH2 ADGRG1 MCTP2	6.14e-06	172	67	5	e3a8891694343b6b01e80a200ae338d24797e417
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RGPD8 PLCH2 GEMIN5 MCTP2 ZAP70	6.32e-06	173	67	5	5295ed31648abf8edff214cf67cd4769f20f9e6d
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LMNB1 H1-3 H1-5 CPSF1 H1-1	6.68e-06	175	67	5	3bca1aac2a2a1f46753b5f9462888f144ed8327b
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FEZF2 VWA5A PIWIL4 MCTP2 UTRN	6.87e-06	176	67	5	ed421d8525108d2f585265d2cf777f07b29f44f0
ToppCell	droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EOMES MYC ADGRG1 UTRN ZAP70	7.25e-06	178	67	5	8aef208b6351143562c87715bb11628880abce94
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EOMES LMNB1 KCNC1 H1-5 ZAP70	7.66e-06	180	67	5	8cef63866c205df3825df84ce51fa61aa04ae491
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EOMES KCNC1 STRBP PLCH2 ANO3	7.66e-06	180	67	5	f6a2208960d0df1500c974cc44c3c054cd7475a9
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EOMES KCNC1 MCTP2 UTRN ZAP70	7.87e-06	181	67	5	9c4f9abb9335da2b07644bca8faff1baa1bb9f5b
ToppCell	LV-17._Lymphocyte\|LV / Chamber and Cluster_Paper	EOMES H1-3 SPOCK2 MCTP2 ZAP70	7.87e-06	181	67	5	81fafa69c8c240250a667a5f3b321e8be1b9a288
ToppCell	T_cells-Resident_memory_CD8+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	COL6A1 MYO7A STRBP PLCH2 SMPD3	8.08e-06	182	67	5	111d434b89902ec11fb07f41b8ee1a98f3991b61
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LMNB1 H1-5 H1-1 GFRA1 MYBPC2	8.98e-06	186	67	5	3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LMNB1 H1-5 H1-1 GFRA1 MYBPC2	8.98e-06	186	67	5	ec6d0c29e196e374baa96dd3d506f489c959e77e
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LMNB1 H1-3 H1-5 H1-1 GFRA1	9.45e-06	188	67	5	33afe31b1093d317dc38c324197c6e91bf6c39d3
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNC1 STRBP PLCH2 SPTBN2 ANO3	9.70e-06	189	67	5	3d838da870623a6a278ddc8e6cedca85d9877e50
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG1 SPOCK2 UTRN ZAP70 RGPD5	9.70e-06	189	67	5	0e8d1be3c406d1a393e18faccfe89116a8f82bcf
ToppCell	Control-Lymphoid_T/NK-NK_CD56bright\|Control / Disease group, lineage and cell class	EOMES PLCH2 MCTP2 UTRN ZAP70	1.02e-05	191	67	5	e842f29bc03ed6734b2a7b975e7830a498f2743c
ToppCell	(210)_NKT_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	DLG5 PLCH2 ADGRG1 SPOCK2 ZAP70	1.05e-05	192	67	5	08dc0c019c594da7b9944db8fd706aa7780e6ae9
ToppCell	10x5'v1-week_17-19-Lymphocytic_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	EOMES DLG5 ADGRG1 SPOCK2 ZAP70	1.05e-05	192	67	5	63e815664b228575886396387d2738cd73855759
ToppCell	(21)_NKT_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	DLG5 PLCH2 ADGRG1 SPOCK2 ZAP70	1.05e-05	192	67	5	b0a573ddde2978485a857b8261ee1ee5ef68ecef
ToppCell	10x5'v1-week_17-19-Lymphocytic_NK-T_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	EOMES DLG5 ADGRG1 SPOCK2 ZAP70	1.05e-05	192	67	5	095151a4f878944835945f698aa0e3b540ffc8c3
ToppCell	background-NK_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.07e-05	193	67	5	f8d6eff1e04926f85d265ec39fe66897fe29574d
ToppCell	Control-Lymphocyte-T_NK\|Control / Disease, Lineage and Cell Type	EOMES MYC ADGRG1 SPOCK2 ZAP70	1.07e-05	193	67	5	eb8b8f6e52fd140fbacf3d6776458c6fc355e120
ToppCell	Mild_COVID-19-T/NK-NK\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	EOMES MYC ADGRG1 MCTP2 ZAP70	1.07e-05	193	67	5	9c455d9d845fa230e9a61d9a5f9d6a2ccf5d7350
ToppCell	367C-Lymphocytic-NK_cells\|367C / Donor, Lineage, Cell class and subclass (all cells)	EOMES PLCH2 ADGRG1 MCTP2 ZAP70	1.10e-05	194	67	5	2e447de50b3f4b59e3b9928df83879955fed93cc
ToppCell	wk_15-18-Hematologic_Lymphocytic-NK-Cycling_NK\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	EOMES H1-3 H1-5 ADGRG1 ZAP70	1.10e-05	194	67	5	af08047e5728ee8198d2686af6a774f2acfa58ba
ToppCell	COVID-19_Severe-CD8+_Tem\|World / disease group, cell group and cell class	EOMES H1-3 ADGRG1 SPOCK2 ZAP70	1.10e-05	194	67	5	60aa16e166894e3fcd82f7a54607c2c02e55b614
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.13e-05	195	67	5	609732e83ab7fc3ba7dace66f5a17e46557fd6d1
ToppCell	Biopsy_Control_(H.)-Immune-pDCs\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	SLC35F3 H1-3 H1-5 SMPD3 RGPD5	1.13e-05	195	67	5	47d139215f0b51f5ea9b5fb09b1100e320e3f1e2
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LMNB1 STRBP H1-5 H1-1 GFRA1	1.13e-05	195	67	5	294c74336fafc1bad237d851efb4a487475078eb
ToppCell	facs-Thymus-nan-3m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LMNB1 STRBP H1-3 H1-5 H1-1	1.13e-05	195	67	5	79114b3c78cc15c413bb58f0673e7215b784a9b6
ToppCell	BAL-Mild-Lymphocyte-T/NK-NK_cell-NK-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	EOMES MYC ADGRG1 MCTP2 ZAP70	1.13e-05	195	67	5	234666fb7a1fd7e33bb7e54fd4004649ce22de70
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LMNB1 STRBP H1-5 H1-1 GFRA1	1.13e-05	195	67	5	5749ea833be84e262e3d0a4fe1a9a373f0ef545f
ToppCell	BAL-Mild-Lymphocyte-T/NK-NK_cell-NK\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	EOMES MYC ADGRG1 MCTP2 ZAP70	1.13e-05	195	67	5	f0fb039f3d2e36acb258afb8b6d2fed20c395c36
ToppCell	BAL-Mild-Lymphocyte-T/NK-NK_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	EOMES MYC ADGRG1 MCTP2 ZAP70	1.13e-05	195	67	5	c7743d8c57584d29cca69c6405f1df6718174582
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	EOMES ADGRG1 SPOCK2 UTRN ZAP70	1.13e-05	195	67	5	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	EOMES ADGRG1 SPOCK2 UTRN ZAP70	1.16e-05	196	67	5	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EOMES ADGRG1 SPOCK2 UTRN ZAP70	1.16e-05	196	67	5	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.16e-05	196	67	5	78b28b263deaa43590b38597186222c6447ad25f
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	EOMES ADGRG1 SPOCK2 UTRN ZAP70	1.16e-05	196	67	5	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EOMES ADGRG1 SPOCK2 UTRN ZAP70	1.16e-05	196	67	5	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.16e-05	196	67	5	3e78e307c9c991c1aadc85c61d401431cf75eaec
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.16e-05	196	67	5	f0566f2ef96584ed6d9247b149218376fb509915
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	EOMES MYC ADGRG1 SPOCK2 ZAP70	1.19e-05	197	67	5	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	EOMES ADGRG1 SPOCK2 UTRN ZAP70	1.19e-05	197	67	5	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DLG5 MCTP2 UTRN ZAP70 RGPD5	1.19e-05	197	67	5	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EOMES H1-3 ADGRG1 MCTP2 ZAP70	1.19e-05	197	67	5	550cce374332c49893bcf4ce4b7dceb7f5fe26aa
ToppCell	COVID-19\|World / Condition, Lineage and Cell class	LMNB1 H1-5 SPOCK2 UTRN ZAP70	1.19e-05	197	67	5	228f641d79282cc3dc51b95a1f4b0cccfc200735
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-ILC\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	EOMES MYO7A H1-3 MCTP2 ZAP70	1.19e-05	197	67	5	9791923feefbd78810242113ad2a08ce4c2bb4f2
ToppCell	343B-Lymphocytic-NK_cells\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	EOMES ADGRG1 ACAA2 MCTP2 ZAP70	1.19e-05	197	67	5	e1009fa54d365a7f4345fef836da6076b5c1c3d0
ToppCell	COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	EOMES ADGRG1 SPOCK2 UTRN ZAP70	1.19e-05	197	67	5	d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.21e-05	198	67	5	d7053a898e04478c577381085f615edaad3cdc5b
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EOMES H1-3 ADGRG1 UTRN ZAP70	1.21e-05	198	67	5	58d805e827299292750b09c6283fdbe406b75f79
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EOMES H1-3 ADGRG1 UTRN ZAP70	1.21e-05	198	67	5	34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe
ToppCell	healthy_donor-Lymphocytic-ILC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.21e-05	198	67	5	aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EOMES H1-3 ADGRG1 MCTP2 ZAP70	1.21e-05	198	67	5	5607e36f393cb399fcc2504502498453fd32d96b
ToppCell	COVID-19_Moderate-NK\|World / disease group, cell group and cell class	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.24e-05	199	67	5	c41b67b760831c7d5e19fabcc932a056dc560f93
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EOMES LMNB1 H1-3 H1-5 ZAP70	1.24e-05	199	67	5	ef767641b669eb2ef3461e51548f4dd09292de90
ToppCell	distal-Hematologic-Natural_Killer-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EOMES H1-3 ADGRG1 MCTP2 ZAP70	1.24e-05	199	67	5	928b152f3bade90dfdb15e46aaa0c85063db0026
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.24e-05	199	67	5	4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	EOMES H1-3 ADGRG1 SPOCK2 ZAP70	1.24e-05	199	67	5	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.24e-05	199	67	5	eb05ccae5187e4701bbbe6d714a6d2808fbcf306
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.24e-05	199	67	5	10c8729b779073c3bf808e85958d59147f0be5c5
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.24e-05	199	67	5	867fd292f3879982422e840e087bfdb3b21a8715
ToppCell	Control-Lymphoid_T/NK-NK\|Control / Disease group, lineage and cell class	EOMES ADGRG1 MCTP2 UTRN ZAP70	1.24e-05	199	67	5	94b2693a8378b9b2c58c6aebb2c6658d75b2e3de
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	VWA5A PIWIL4 MCTP2 UTRN GFRA1	1.27e-05	200	67	5	501cd2b4e55444fc5fdd93ebbcfc0616442b110b
ToppCell	severe-NK_CD56bright\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	EOMES PLCH2 H1-3 MCTP2 ZAP70	1.27e-05	200	67	5	2e67068b98696c313b815a2f0c98643f892e8bc0
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	EOMES PLCH2 SPOCK2 MCTP2 ZAP70	1.27e-05	200	67	5	580fbf9fcb78357a081e5f5af06113ca33d44581
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated\|COVID-19_Severe / Disease, condition lineage and cell class	EOMES H1-3 MCTP2 UTRN ZAP70	1.27e-05	200	67	5	6a77f9643646bafc1157bf1fc1e4c614860ee642
ToppCell	Biopsy_IPF-Immune-Proliferating_T_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	LMNB1 H1-3 H1-5 SPOCK2 ZAP70	1.27e-05	200	67	5	c43d1a83b2a8ad060f3d80c9438da8b7a5e307fb
ToppCell	COVID-19_Severe-MAIT\|World / disease group, cell group and cell class	EOMES MYC COL6A1 SPOCK2	6.77e-05	145	67	4	8d63f97812f63329ef9c940b291dc5a1c4d90690
ToppCell	COVID-19_Severe-MAIT\|COVID-19_Severe / disease group, cell group and cell class	EOMES MYC COL6A1 SPOCK2	7.73e-05	150	67	4	923ea7ecc0aa05fb0396082cd9c3d1594135f1e0
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SPTBN5 COL6A1 FEZF2 ANO3	7.93e-05	151	67	4	f50c5ae9dae507df750df25e151b58685fec70ce
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SPTBN5 COL6A1 FEZF2 ANO3	8.56e-05	154	67	4	12cbc38bc1f7231c67e1d2d5e86e95bc12e24682
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SPTBN5 COL6A1 FEZF2 ANO3	8.99e-05	156	67	4	fe383ce3a0c37f7343d7026cb51260a04d4c2829
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_C\|367C / Donor, Lineage, Cell class and subclass (all cells)	EOMES ADGRG1 MCTP2 ZAP70	8.99e-05	156	67	4	a1b9e7621b646d354c2ccd850ce6a4fa9ff8a026
Drug	spermine	SPTBN5 PIK3C2A PIK3R2 SPTBN2 H1-3 H1-5 H1-1 CEP131 SMPD3 SEC14L2	2.22e-07	394	67	10	CID000001103
Drug	AC1L9HHR	SPTBN5 LMNB1 PIK3C2A ACLY SPTBN2 H1-3 H1-5 H1-1 SMPD3	9.28e-07	354	67	9	CID000445141
Drug	AC1L1KMJ	SPTBN5 COL6A1 EPS15 EPS15L1 PIK3C2A MYO7A PIK3R2 SPTBN2 CAST ZAP70	1.24e-06	476	67	10	CID000030956
Drug	Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; MCF7; HT_HG-U133A	MYO7A VWA5A SPTBN2 CPSF1 SPOCK2 ACAA2 MCTP2	2.02e-06	200	67	7	5454_UP
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	COL6A1 DLG5 LMNB1 H1-3 TLN2 MAST2	2.36e-05	195	67	6	4019_DN
Drug	Amphotericin B [1397-89-3]; Up 200; 4.4uM; PC3; HT_HG-U133A	SPTBN5 DLG5 MYO7A ERAP1 SPTBN2 ADGRG1	2.36e-05	195	67	6	6303_UP
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A	DLG5 LMNB1 MYO7A H1-3 TLN2 MCTP2	2.50e-05	197	67	6	3862_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	LMNB1 ERAP1 H1-3 RBM5 MAST2 UTRN	2.50e-05	197	67	6	3750_DN
Drug	3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; PC3; HT_HG-U133A	VWA5A DNAH17 RBM5 TLN2 SPOCK2 MAST2	2.57e-05	198	67	6	4601_UP
Drug	Androsterone [53-41-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A	COL6A1 SPTBN2 CAST TLN2 MCTP2 SEC14L2	2.57e-05	198	67	6	2650_UP
Drug	celecoxib; Up 200; 10uM; PC3; HG-U133A	H1-3 RBM5 CPSF1 TLN2 ACAA2 MAST2	2.57e-05	198	67	6	482_UP
Drug	Bumetanide [28395-03-1]; Up 200; 11uM; PC3; HT_HG-U133A	SPTBN5 COL6A1 LMNB1 VWA5A DNAH17 H1-3	2.57e-05	198	67	6	5117_UP
Drug	Prostaglandin E1; Down 200; 10uM; MCF7; HT_HG-U133A	DLG5 LMNB1 VWA5A H1-3 RBM5 UTRN	2.57e-05	198	67	6	6576_DN
Drug	Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	NPL SPTBN5 VWA5A DNAH17 RBM5 MAST2	2.65e-05	199	67	6	1521_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HG-U133A	VWA5A CPSF1 TLN2 ACAA2 CEP131 UTRN	2.65e-05	199	67	6	122_UP
Drug	Ciprofibrate [52214-84-3]; Down 200; 13.8uM; PC3; HT_HG-U133A	COL6A1 ERAP1 RBM5 TLN2 CEP131 UTRN	2.65e-05	199	67	6	5740_DN
Drug	Zlllal	MYC LMNB1 PIK3C2A PIK3R2 CAST H1-3 H1-5 H1-1 APOB	7.45e-05	613	67	9	CID000107707
Drug	NSC618487	MYC LMNB1 PIK3C2A PIK3R2 CAST H1-3 H1-5 H1-1 APOB SMPD3 ZAP70	8.10e-05	933	67	11	CID000005279
Drug	spermidine	MYC H1-3 H1-5 H1-1 CEP131 SEC14L2	1.00e-04	253	67	6	CID000001102
Drug	3-deazaadenosine	MYC APOB	1.27e-04	6	67	2	ctd:C018258
Drug	sterol	LMNB1 ACLY NUP133 ACAA2 APOB SMPD3	1.29e-04	265	67	6	CID000001107
Drug	Pluronic	FEZF2 PIK3R2 APOB UTRN	1.45e-04	90	67	4	CID000024751
Drug	3-tert-butylphenyl-N-methyl-carbamate	H1-3 H1-5 H1-1	1.62e-04	36	67	3	CID000013072
Drug	heparin disaccharide iii-S	H1-3 H1-5 H1-1	1.76e-04	37	67	3	CID000448838
Drug	PSA11-SPM	APOB SMPD3	1.77e-04	7	67	2	CID006439362
Drug	polyarginine	H1-3 H1-5 H1-1 APOB	1.78e-04	95	67	4	CID000072364
Drug	32 P	MYC SPTBN5 SPTBN2 H1-3 H1-5 H1-1 APOB	1.86e-04	405	67	7	CID000448772
Drug	Dieldrin	EOMES MYC DLG5 LMNB1 VWA5A ACLY PIK3R2 NUP133 APOB SMPD3 BZW1 GFRA1	2.01e-04	1217	67	12	ctd:D004026
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	COL6A1 SPTBN2 H1-3 RBM5 UTRN	2.38e-04	189	67	5	3788_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	COL6A1 VWA5A PIK3R2 H1-3 SPOCK2	2.44e-04	190	67	5	4322_DN
Drug	PtdIns(4)P	KCNC1 PIK3C2A PIK3R2 CAST	2.52e-04	104	67	4	CID000643965
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DLG5 SPTBN2 RBM5 MAST2 UTRN	2.56e-04	192	67	5	6054_DN
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	NPL DLG5 EPS15L1 PIK3R2 RBM5	2.56e-04	192	67	5	6025_DN
Drug	Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A	COL6A1 LMNB1 H1-3 SPOCK2 ACAA2	2.62e-04	193	67	5	5268_UP
Drug	Paclitaxel [33069-62-4]; Up 200; 4.6uM; PC3; HT_HG-U133A	EPS15L1 ERAP1 VWA5A DAPK1 MCTP2	2.62e-04	193	67	5	6720_UP
Drug	ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A	LMNB1 MYO7A H1-3 RBM5 ADGRG1	2.68e-04	194	67	5	5235_UP
Drug	Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A	COL6A1 SPTBN2 DNAH17 RBM5 LMTK2	2.68e-04	194	67	5	3285_UP
Drug	Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A	ERAP1 DAPK1 TLN2 SPOCK2 APOB	2.68e-04	194	67	5	4552_UP
Drug	STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A	LMNB1 PIK3R2 H1-3 LMTK2 MAST2	2.75e-04	195	67	5	6561_UP
Drug	diclofenac sodium; Up 200; 10uM; PC3; HG-U133A	VWA5A CPSF1 TLN2 APOB UTRN	2.75e-04	195	67	5	445_UP
Drug	Spkk	H1-3 H1-5 H1-1	2.76e-04	43	67	3	CID000129363
Drug	POPC	SPTBN5 PIK3C2A ACLY SPTBN2 APOB SMPD3	2.81e-04	306	67	6	CID000065167
Drug	Boldine [476-70-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DLG5 VWA5A SPTBN2 LMTK2 ADGRG1	2.81e-04	196	67	5	4122_DN
Drug	Racecadotril [81110-73-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A	SPTBN5 COL6A1 LMNB1 H1-3 MAST2	2.81e-04	196	67	5	2774_UP
Drug	Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A	H1-3 ADGRG1 ACAA2 MCTP2 ANO3	2.81e-04	196	67	5	6821_UP
Drug	Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A	SPTBN5 MYO7A SPTBN2 SPOCK2 SEC14L2	2.81e-04	196	67	5	5251_UP
Drug	Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; HL60; HG-U133A	MED24 EPS15L1 PIK3R2 ADGRG1 SPOCK2	2.88e-04	197	67	5	1389_UP
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A	COL6A1 VWA5A CAST H1-3 MAST2	2.88e-04	197	67	5	3728_DN
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	COL6A1 VWA5A TLN2 SPOCK2 UTRN	2.88e-04	197	67	5	4336_DN
Drug	Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; MCF7; HT_HG-U133A	ERAP1 DNAH17 TLN2 SPOCK2 UTRN	2.88e-04	197	67	5	6237_UP
Drug	Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A	SPTBN5 ERAP1 VWA5A PIK3R2 LMTK2	2.88e-04	197	67	5	3567_UP
Drug	Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A	VWA5A SPTBN2 DNAH17 RBM5 ACAA2	2.88e-04	197	67	5	2275_DN
Drug	CGP 41251	CAST H1-3 H1-5 H1-1	2.92e-04	108	67	4	CID000104937
Drug	Enoxacin [74011-58-8]; Up 200; 12.4uM; PC3; HT_HG-U133A	COL6A1 DLG5 ADGRG1 TLN2 MCTP2	2.95e-04	198	67	5	4655_UP
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; PC3; HT_HG-U133A	COL6A1 H1-3 RBM5 LMTK2 TLN2	2.95e-04	198	67	5	3730_DN
Drug	Tridihexethyl chloride; Up 200; 11.4uM; PC3; HT_HG-U133A	MYO7A ERAP1 TLN2 APOB SEC14L2	2.95e-04	198	67	5	5067_UP
Drug	Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; PC3; HT_HG-U133A	COL6A1 LMTK2 TLN2 MAST2 SEC14L2	2.95e-04	198	67	5	6637_UP
Drug	Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; HL60; HT_HG-U133A	COL6A1 MYO7A CPSF1 SPOCK2 ZAP70	2.95e-04	198	67	5	6160_UP
Drug	Ethoxyquin [91-53-2]; Up 200; 18.4uM; HL60; HT_HG-U133A	MYO7A RBM5 TLN2 SPOCK2 ACAA2	2.95e-04	198	67	5	2559_UP
Drug	sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A	SPTBN5 MYO7A CPSF1 TLN2 ACAA2	2.95e-04	198	67	5	407_DN
Drug	Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A	SPTBN5 COL6A1 VWA5A DAPK1 SPOCK2	2.95e-04	198	67	5	4761_UP
Drug	Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; MCF7; HT_HG-U133A	ERAP1 H1-5 MAST2 MCTP2 UTRN	2.95e-04	198	67	5	3550_UP
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	COL6A1 VWA5A DNAH17 ACAA2 MAST2	2.95e-04	198	67	5	2251_DN
Drug	Griseofulvin [126-07-8]; Up 200; 11.2uM; HL60; HT_HG-U133A	COL6A1 KCNC1 MYO7A VWA5A H1-3	2.95e-04	198	67	5	2332_UP
Drug	Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A	COL6A1 LMNB1 DNAH17 H1-3 RBM5	2.95e-04	198	67	5	7023_UP
Drug	Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; HL60; HG-U133A	NPL DLG5 EPS15L1 CAST SPOCK2	3.02e-04	199	67	5	2023_UP
Drug	PF-00539758-00 [351321-34-1]; Down 200; 10uM; MCF7; HT_HG-U133A	SPTBN5 COL6A1 SPTBN2 CPSF1 SEC14L2	3.02e-04	199	67	5	6416_DN
Drug	Ribavirin [36791-04-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A	EPS15L1 KCNC1 LMTK2 SPOCK2 UTRN	3.02e-04	199	67	5	6521_UP
Drug	Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A	SPTBN5 COL6A1 LMTK2 MCTP2 UTRN	3.02e-04	199	67	5	3205_UP
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; PC3; HT_HG-U133A	COL6A1 VWA5A PLCH2 ADGRG1 TLN2	3.02e-04	199	67	5	4666_UP
Drug	Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A	LMNB1 SPTBN2 SPOCK2 ACAA2 MCTP2	3.09e-04	200	67	5	6075_UP
Drug	Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; PC3; HT_HG-U133A	DLG5 DNAH17 H1-3 RBM5 MAST2	3.09e-04	200	67	5	4014_DN
Drug	Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A	DLG5 EPS15L1 PIK3R2 CAST UTRN	3.09e-04	200	67	5	5521_UP
Drug	cytosine	MYC H1-3 H1-5 DAPK1 H1-1 APOB UPP2	3.12e-04	441	67	7	CID000000597
Drug	GH 5	H1-3 H1-5 H1-1	3.16e-04	45	67	3	CID000163897
Disease	Hematopoetic Myelodysplasia	MYC DAPK1 SMPD3	3.75e-05	29	66	3	C2713368
Disease	congenital muscular dystrophy (implicated_via_orthology)	COL6A1 LMNB1	7.35e-05	6	66	2	DOID:0050557 (implicated_via_orthology)
Disease	endoplasmic reticulum aminopeptidase 1 measurement	ERAP1 CAST	1.03e-04	7	66	2	EFO_0008119
Disease	myopathy (implicated_via_orthology)	NPL LMNB1 MYBPC2	1.72e-04	48	66	3	DOID:423 (implicated_via_orthology)
Disease	uveitis	ERAP1 CAST	1.76e-04	9	66	2	EFO_1001231
Disease	Hirschsprung's disease (implicated_via_orthology)	MED24 GFRA1	3.21e-04	12	66	2	DOID:10487 (implicated_via_orthology)
Disease	MYELODYSPLASTIC SYNDROME	MYC DAPK1 SMPD3	4.62e-04	67	66	3	C3463824
Disease	alcohol dependence	COL6A1 ZNF532 ERAP1 CAST	7.64e-04	183	66	4	MONDO_0007079
Disease	Hodgkins lymphoma	EOMES ERAP1 CAST	8.34e-04	82	66	3	EFO_0000183
Disease	muscular dystrophy (implicated_via_orthology)	LMNB1 UTRN	1.01e-03	21	66	2	DOID:9884 (implicated_via_orthology)
Disease	smoking status measurement, chronic obstructive pulmonary disease	MED24 H1-5 SMPD3	1.02e-03	88	66	3	EFO_0000341, EFO_0006527
Disease	hemoglobin A1 measurement	EOMES DLG5 LCORL CAST MAST2 ANO3	1.08e-03	520	66	6	EFO_0007629
Disease	Behcet Syndrome	ERAP1 APOB	1.32e-03	24	66	2	C0004943
Disease	myeloperoxidase measurement	MED24 NUP133	1.55e-03	26	66	2	EFO_0005243

Protein segments in the cluster

Peptide	Gene	Start	Entry
LDLDKASKKFSGSLS	EOMES	46	O95936
ASEAALFLKKSGLSD	EPS15L1	36	Q9UBC2
RDAADFLLKASSVFK	DAPK1	1386	P53355
DLEAVAKFLDASGAK	BZW1	46	Q7L1Q6
SLAALKKALAAAGYD	H1-1	61	Q02539
AATGFLKLLADKNSE	DIS3L2	246	Q8IYB7
FADLSDFCLALGKDK	ANO3	96	Q9BYT9
FSDGDAKLERLAAKF	RGPD5	1136	Q99666
FSDGDAKLERLAAKF	RGPD8	1136	O14715
KAFSGDVSKLSLADS	FHDC1	226	Q9C0D6
LGLSKLAALASDFSE	NUP133	971	Q8WUM0
LKAADLLAADFSGKS	MCTP2	516	Q6DN12
LKSLDLSFNSLKDDG	NLRP8	926	Q86W28
RSAEFADGLLSKALK	LCORL	271	Q8N3X6
DAALATALGDKKSLE	LMNB1	146	P20700
LAGAKRDALLLSFKD	CPSF1	86	Q10570
ALLFDAEKSSASSKL	ERAP1	331	Q9NZ08
KDSSLGLSKEDKAFL	PIK3C2A	881	O00443
KDGKDLLALDAFSSD	DLG5	1701	Q8TDM6
KDAAKEAGLVSALSS	LMTK2	956	Q8IWU2
KCNDDALASKGALFL	SMPD3	426	Q9NY59
AAAAAKLDGTLSVDL	ODAD1	506	Q96M63
DFAKSARKDLVLSDG	RBM5	311	P52756
DTAALADGIKSFLLA	PIK3R2	166	O00459
EKRLFDASSFGKDLL	SLC25A31	11	Q9H0C2
KFSLDGKAALTELSL	APOB	1696	P04114
SGLSSKAAKDVLGFL	KCNC1	296	P48547
SLAALKKALAAGGYD	H1-5	61	P16401
SSGAAKKRLLLFSDG	COL6A1	931	P12109
ASTKKFFDDLGDELL	DNAH17	2711	Q9UFH2
KETNFSLASGLEAKD	GFRA1	56	P56159
AAAAKFTGLSKEELL	SLC3A2	156	P08195
GKRDFLLSDKASSLL	ADGRG1	106	Q9Y653
AFKLFDDDDSGKISL	CETN3	106	O15182
SSLKFEDAKLAAAIS	CAST	526	P20810
LAAALAASEKKLATS	MAST2	1411	Q6P0Q8
ASDAAAFLKKSGLPD	EPS15	36	P42566
SGVSLAALKKALAAA	H1-3	56	P16402
DQGKLAAAKSLDFFR	DENND1B	581	Q6P3S1
LDAKGLLFSASKQDL	SEC14L2	106	O76054
DASSLTADNLEKFGK	CEP131	496	Q9UPN4
FLLENAKLAGLAADK	FEZF2	211	Q8TBJ5
KSLDFLSFTDLKDGN	NPL	301	Q9BXD5
LDGALCSFSREKKLD	UPP2	226	O95045
LSQADGSFLKEKLAG	UTRN	2046	P46939
SGFSAAAKLVSEKLA	MYC	136	P01106
KSLDLLLAAAAATGK	MED24	446	O75448
LLAAAAATGKLKSFA	MED24	451	O75448
SNKAKAFDGAILFLS	PIWIL4	151	Q7Z3Z4
VAKASAALAALEKLF	STRBP	561	Q96SI9
SGKTALLFAAALEAA	SWSAP1	16	Q6NVH7
LFKLLLGSAKFGEAA	SLC35F3	251	Q8IY50
DKEEFGASAALLSTK	SPTBN5	166	Q9NRC6
AYIADLDAKSGASLK	ACLY	251	P53396
DLSEFAAKAALSAGK	ACAA2	31	P42765
IAAIAALSAKKAASD	ZNF532	271	Q9HCE3
KISDFGLSKALGADD	ZAP70	476	P43403
LADGKKAALTSALSI	SPTBN2	946	O15020
AAKSKSLGDLTADDF	PLCH2	1251	O75038
KKGDAASLRTAAELA	GEMIN5	1061	Q8TEQ6
ASDKKDALNLSLESG	VWA5A	566	O00534
LLEAGSLKLDAAATA	ZNF827	126	Q17R98
LGAAASIEAAAKKLE	TLN2	2311	Q9Y4G6
SKALIASAGADALAK	STRN4	736	Q9NRL3
AVLFASKAGAAGKDL	WDR11	1196	Q9BZH6
LAAAALAEGDAKGLK	SPOCK2	16	Q92563
ALADKISLKDRFGFS	MYO7A	1286	Q13402
SDTAGELDFSGLLKK	MYBPC2	176	Q14324